C.C. Hadjikostas
About
In The Last Decade
C.C. Hadjikostas
28 papers receiving 335 citations
Peers
Comparison fields: 5 of 42
- Oncology 218
- Organic Chemistry 213
- Inorganic Chemistry 189
- Electronic, Optical and Magnetic Materials 113
- Materials Chemistry 106
Countries citing papers authored by C.C. Hadjikostas
This map shows the geographic impact of C.C. Hadjikostas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.C. Hadjikostas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.C. Hadjikostas more than expected).
Fields of papers citing papers by C.C. Hadjikostas
This network shows the impact of papers produced by C.C. Hadjikostas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.C. Hadjikostas. The network helps show where C.C. Hadjikostas may publish in the future.
Co-authorship network of co-authors of C.C. Hadjikostas
This figure shows the co-authorship network connecting the top 25 collaborators of C.C. Hadjikostas. A scholar is included among the top collaborators of C.C. Hadjikostas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.C. Hadjikostas. C.C. Hadjikostas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Cytotoxic effects of a mixed ligand copper(II) chelate complex against a panel of human and murine cancer cells in vitro. Theoretical study of the mechanism of biologic action through molecular modelling. | 2 |
| 2 | 8 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | In vitro combined effect of a new series of copper (II) complexes with cisplatin or epirubicin on human breast and cervical cancer cell lines. | 2 |
| 7 | 8 | |
| 8 | 11 | |
| 9 | 3 | |
| 10 | 5 | |
| 11 | 30 | |
| 12 | 3 | |
| 13 | 5 | |
| 14 | 18 | |
| 15 | 7 | |
| 16 | 44 | |
| 17 | 5 | |
| 18 | 6 | |
| 19 | 16 | |
| 20 | 47 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.